October 14, 2019

Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

PGK1 is a decisive oncogene in patients with SMAD4-negative PDAC and can be a target for the development of a therapeutic strategy for SMAD4-negative PDAC.

Me gusta

Guardar

Cite This Study

Liang et al. (Mon,) studied this question.

synapsesocial.com/papers/69d80f7966a29169b4bee006 https://doi.org/https://doi.org/10.1136/gutjnl-2018-317163

Me gusta

Guardar